Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE

New analysis of the REDUCE-IT trial suggested benefit of icosapent ethyl doesn ' t vary by Lp(a) level and confirmed risk for Lp(a) with high triglycerides but not cholesterol.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news